John Mulcahy is the founder of SiteOne Therapeutics. SiteOne Therapeutics has raised $100M in total funding. Latest round: Series C.
John Mulcahy is a co-founder, President, and Chief Executive Officer at SiteOne Therapeutics, a clinical-stage biopharmaceutical company. The company focuses on developing non-opioid therapeutics for pain and sensory hyperexcitability disorders by advancing selective ion channel modulators.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide